Showing results (51-60 of 157) with videos related to
Sort By:
Pageof 16
Journal of Imaging Informatics in Medicine|September 12, 2024
Convolutional Neural Networks for Segmentation of Pleural Mesothelioma: Analysis of Probability Map Thresholds (CALGB 30901, Alliance)Mena Shenouda, Eyjólfur Gudmundsson, Feng Li, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904Robert A Kratzke, Xiaofei Wang, Long Wong, et al.American Journal of Clinical Oncology|December 4, 2004
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinomaCathy Eng, Ramesh K Ramanathan, Ramesh K Ramathan, et al.International Surgery|October 30, 2012
Three-dimensional stereoscopic volume rendering of malignant pleural mesotheliomaNathan M Mollberg, Nigel M Parsad, Samuel G Armato, et al.British Journal of Cancer|October 26, 2020
Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapyMichael G White, Jefree J Schulte, Lai Xue, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)Andrew B Nixon, Herbert Pang, Mark D Starr, et al.European Journal of Cancer (Oxford, England : 1990)|July 25, 2008
A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumoursSamir D Undevia, Federico Innocenti, Jacqueline Ramirez, et al.Annals of Surgical Oncology|November 17, 2007
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903Mitchell C Posner, Donna Niedzwiecki, Alan P Venook, et al.Journal for Immunotherapy of Cancer|May 16, 2014
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinomaDaniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancerHedy L Kindler, Gregory Friberg, Deepti A Singh, et al.Pageof 16